Vertebrate Antibodies Ltd (VAL) is an emerging biotech company with a focus on the development of monoclonal and polyclonal antibodies to targets within a wide range of organisms for basic, applied and clinical research. VAL aims to support researchers within the life science community by providing high-quality antibodies to novel and in-demand targets to drive the advancement of research. The widespread use of antibodies has led to the rapid development of new techniques. VAL uses a combination of bioinformatics and streamlined modified protocols which have improved the efficiency and sensitivity of their products. To date these antibodies have proven to be invaluable research tools for many research fields.